Home › Cardiomyopathy › Connecticut › New Haven
Cardiomyopathy clinical trials in New Haven, CT
3 studies for Cardiomyopathy are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
RecruitingPhase 3
- Yale University School of Medicine - Section of Cardiology, New Haven
Mechanisms of Diuretic Resistance in Heart Failure, Aim 3
RecruitingPhase 1
- Yale University, New Haven
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
RecruitingPhase 3
- Yale University School of Medicine, New Haven
About Cardiomyopathy
Cardiomyopathy is a disease that causes the heart to become enlarged, thick, or stiff. Read about the different types, their symptoms, and treatments.
More about Cardiomyopathy on MedlinePlus
Cardiomyopathy trials in other cities
- New York City, NY10 studies
- Boston, MA9 studies
- Rochester, MN8 studies
- Washington, DC8 studies
- San Diego, CA7 studies
- Baltimore, MD7 studies
- Indianapolis, IN6 studies
- St. Louis, MO6 studies
- Philadelphia, PA6 studies
- Dallas, TX6 studies
- Charleston, SC6 studies
- Richmond, VA6 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer37 studies
- Cancer (all types)34 studies
- Metastatic Cancer23 studies
- Lung Cancer23 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Colorectal Cancer21 studies
- Prostate Cancer21 studies
- Ovarian Cancer21 studies
- Acute Myeloid Leukemia19 studies
- Alcohol Use Disorder (AUD)17 studies
- Opioid Overdose17 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.